GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/Same-Day Discharge After G-POEM Appears Safe in Selected Patients | Gastrointestinal Endoscopy

Same-Day Discharge After G-POEM Appears Safe in Selected Patients | Gastrointestinal Endoscopy

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated May 1, 2026

Quick Answer

Introduction Gastric per oral endoscopic myotomy (G-POEM) has emerged as an effective minimally invasive therapy for refractory gastroparesis. However, post-procedural care remains variable across centers, with no clear consensus on whether patients require routine overnight observation or can be safely discharged on the same day.


Introduction

Gastric per oral endoscopic myotomy (G-POEM) has emerged as an effective minimally invasive therapy for refractory gastroparesis. However, post-procedural care remains variable across centers, with no clear consensus on whether patients require routine overnight observation or can be safely discharged on the same day.

Problem Statement

Despite growing adoption of G-POEM, the optimal post-procedure disposition remains undefined. Routine overnight admission increases resource utilization and costs, yet concerns persist regarding delayed adverse events, unplanned readmissions and emergency visits after same-day discharge. Defining the safety of same-day discharge is essential to standardize post-G-POEM care and improve procedural efficiency.

Summary

This systematic review and meta-analysis suggests that same-day discharge after G-POEM is a safe and feasible strategy in appropriately selected patients with refractory gastroparesis. Across pooled studies, same-day discharge was not associated with higher rates of readmission, emergency department visits or procedure-related adverse events compared with routine overnight observation. These findings support the clinical safety of same-day discharge when applied in carefully selected patients following uncomplicated procedures. Notably, same-day discharge was also associated with shorter procedure times, suggesting that procedural efficiency and case selection may contribute to successful early discharge pathways. Although patient selection and institutional protocols remain important, these data support a shift toward more streamlined post-G-POEM care and suggest that routine overnight admission may not be necessary for all patients. This analysis provides an important step toward standardizing post-procedural pathways and supports same-day discharge as a practical, resource-conscious approach in experienced centers.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer